Unlocking the Potential of ADC Technology Through Glycosylation: A New Frontier in Targeted Cancer Therapy
Antibody-Drug Conjugates (ADCs) are reshaping modern cancer treatment by offering a more targeted and efficient way to fight tumors¹. Contrary to conventional chemotherapy, which moves to all parts of the body, damaging all healthy and cancerous cells, ADCs target the entire procedure in a surgically correct way. This has made them significantly less harmful to […]
